Experts in viral hepatitis review topics in hepatitis C, hepatitis B, and coinfection using patient case scenarios. Certified for CME/CE credit.
Volume 5, Issue 12
In this podcast Dr. Ira Jacobson discusses New Options for Patients with “Hard-To-Treat” Hepatitis C Infection.
Volume 5, Issue 10
In this podcast Dr. David Wyles discusses managing DAA failures with the newly approved treatment options for hepatitis C.
Volume 5, Issue 8
In this podcast, Andrew J. Muir, MD from Duke University School of Medicine discusses the real-world data to support a sofosbuvir-ledipasvir treatment duration of 8 weeks versus 12 weeks, summarizes the current hepatitis C treatment options for patients with advanced kidney disease, and describes the risks and benefits of hepatitis C therapies in HIV-HCV coinfected patients.
Volume 5, Issue 6
this podcast, Andrew H. Talal, MD, MPH and Richard Blondell, MD from the University at Buffalo discuss expanding HCV screening in persons with substance abuse disorders.
Volume 5, Issue 4
In this podcast Daryl T. Y. Lau, MD, MSc, MPH from Harvard Medical School discussed how to evaluate and mange patients who do not meet treatment criteria, the management of chronic hepatitis B during pregnancy, and how to identify patients appropriate for tenofovir alafenamide (TAF) therapy.
Volume 5, Issue 2
Our guests authors are Mindie Nguyen, MD, MAS, from Associate Professor of Medicine at Stanford University, and Dr. Iris Liou, MD of the University of Washington.
Customer ReviewsSee All
Great resource, i can listen to the CME and then take the posttest later...Good work!